Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rechelist Pharma is an Indian pharmaceutical company that operates as a division of Biophar Lifesciences. The company specializes in the manufacturing, marketing, and distribution of a wide range of healthcare products, including tablets, capsules, injectables, and nutraceuticals. It is primarily recognized for its PCD (Propaganda Cum Distribution) Pharma Franchise model and its third-party manufacturing services. Rechelist Pharma's product portfolio covers diverse therapeutic areas such as anti-infectives, gastroenterology, gynecology, and dermatology. The company emphasizes adherence to WHO-GMP and ISO quality standards to provide affordable and effective healthcare solutions across the Indian market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rech Elist Pharma.